Latest developments and future directions of perioperative immunotherapy in bladder cancer
A. Necchi, Milan (IT)
Old paradigms and next destinations of perioperative immune-checkpoint inhibition in kidney cancer
A. Bex, London (GB)
Clinical case-series: Perioperative treatment with immune-checkpoint inhibitors in bladder and renal cancer
J. Bedke, Tübingen (DE)
To provide all the physicians and healthcare providers involved in the treatment of urologic tumors with the state-of-the art on the use of immune-checkpoint inhibitors in bladder and kidney cancers.
To provide urologists with an overview of the ongoing clinical trials throughout the clinical stages, with a special focus on neoadjuvant and adjuvant stages.
To discuss the optimal clinical management of perioperative immunotherapy, the alternative therapeutic solutions, and the major challenges to the use of checkpoint inhibition in early-stage disease.